NERV position history
The shares of Minerva Neurosciences (NERV) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q4: 2,365,000 shares, $9.5M, 0.04% of portfolio, New
- 2026 Q1: 2,365,000 shares, $14M, 0.08% of portfolio
- 2026 Q2: 2,365,000 shares, $13M, 0.06% of portfolio
- 2026 Q3: 2,365,000 shares, $7.9M, 0.03% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|